Continuing Medical Education: SSRIs and Pregnancy

Overview

Journal Indian J Psychiatry

Specialty Psychiatry

Date 2010 Feb 23

PMID 20174529

Citations 1

Authors

Chittaranjan Andrade

Affiliations

Soon will be listed here.

Citing Articles

How to read a research paper: Reading between and beyond the lines.

Andrade C Indian J Psychiatry. 2012; 53(4):362-6.

PMID: 22303047 PMC: 3267350. DOI: 10.4103/0019-5545.91912.

References

Bar-Oz B, Einarson T, Einarson A, Boskovic R, OBrien L, Malm H . Paroxetine and congenital malformations: meta-Analysis and consideration of potential confounding factors. Clin Ther. 2007; 29(5):918-926. DOI: 10.1016/j.clinthera.2007.05.003. View

Levinson-Castiel R, Merlob P, Linder N, Sirota L, Klinger G . Neonatal abstinence syndrome after in utero exposure to selective serotonin reuptake inhibitors in term infants. Arch Pediatr Adolesc Med. 2006; 160(2):173-6. DOI: 10.1001/archpedi.160.2.173. View

Nonacs R, Cohen L . Assessment and treatment of depression during pregnancy: an update. Psychiatr Clin North Am. 2003; 26(3):547-62. DOI: 10.1016/s0193-953x(03)00046-7. View

Chung T, Lau T, Yip A, Chiu H, Lee D . Antepartum depressive symptomatology is associated with adverse obstetric and neonatal outcomes. Psychosom Med. 2001; 63(5):830-4. DOI: 10.1097/00006842-200109000-00017. View

Oberlander T, Warburton W, Misri S, Aghajanian J, Hertzman C . Neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health data. Arch Gen Psychiatry. 2006; 63(8):898-906. DOI: 10.1001/archpsyc.63.8.898. View

Merlob P, Birk E, Sirota L, Linder N, Berant M, Stahl B . Are selective serotonin reuptake inhibitors cardiac teratogens? Echocardiographic screening of newborns with persistent heart murmur. Birth Defects Res A Clin Mol Teratol. 2009; 85(10):837-41. DOI: 10.1002/bdra.20615. View

Brettingham M . Depression and obesity are major causes of maternal death in Britain. BMJ. 2004; 329(7476):1205. PMC: 529359. DOI: 10.1136/bmj.329.7476.1205. View

Nielsen R, Stage K, Christensen P, Mortensen S, Andersen L, Damkier P . [Medical treatment of depression during pregnancy and breastfeeding]. Ugeskr Laeger. 2007; 169(16):1442-4. View

Chambers C, Hernandez-Diaz S, Van Marter L, Werler M, Louik C, Jones K . Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn. N Engl J Med. 2006; 354(6):579-87. DOI: 10.1056/NEJMoa052744. View

10.

Kallen B, Olausson P . Maternal use of selective serotonin re-uptake inhibitors and persistent pulmonary hypertension of the newborn. Pharmacoepidemiol Drug Saf. 2008; 17(8):801-6. DOI: 10.1002/pds.1570. View

11.

Wichman C, Moore K, Lang T, St Sauver J, Heise Jr R, Watson W . Congenital heart disease associated with selective serotonin reuptake inhibitor use during pregnancy. Mayo Clin Proc. 2009; 84(1):23-7. PMC: 2664566. DOI: 10.4065/84.1.23. View

12.

Cohen L, Altshuler L, Harlow B, Nonacs R, Newport D, Viguera A . Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment. JAMA. 2006; 295(5):499-507. DOI: 10.1001/jama.295.5.499. View

13.

Alwan S, Reefhuis J, Rasmussen S, Olney R, Friedman J . Use of selective serotonin-reuptake inhibitors in pregnancy and the risk of birth defects. N Engl J Med. 2007; 356(26):2684-92. DOI: 10.1056/NEJMoa066584. View

14.

Berard A, Ramos E, Rey E, Blais L, St-Andre M, Oraichi D . First trimester exposure to paroxetine and risk of cardiac malformations in infants: the importance of dosage. Birth Defects Res B Dev Reprod Toxicol. 2006; 80(1):18-27. DOI: 10.1002/bdrb.20099. View

15.

Moses-Kolko E, Bogen D, Perel J, Bregar A, Uhl K, Levin B . Neonatal signs after late in utero exposure to serotonin reuptake inhibitors: literature review and implications for clinical applications. JAMA. 2005; 293(19):2372-83. DOI: 10.1001/jama.293.19.2372. View

16.

Sanz E, De-las-Cuevas C, Kiuru A, Bate A, Edwards R . Selective serotonin reuptake inhibitors in pregnant women and neonatal withdrawal syndrome: a database analysis. Lancet. 2005; 365(9458):482-7. DOI: 10.1016/S0140-6736(05)17865-9. View

17.

Kurki T, Hiilesmaa V, Raitasalo R, Mattila H, Ylikorkala O . Depression and anxiety in early pregnancy and risk for preeclampsia. Obstet Gynecol. 2000; 95(4):487-90. DOI: 10.1016/s0029-7844(99)00602-x. View

18.

Lund N, Pedersen L, Henriksen T . Selective serotonin reuptake inhibitor exposure in utero and pregnancy outcomes. Arch Pediatr Adolesc Med. 2009; 163(10):949-54. DOI: 10.1001/archpediatrics.2009.164. View

19.

Andrade S, McPhillips H, Loren D, Raebel M, Lane K, Livingston J . Antidepressant medication use and risk of persistent pulmonary hypertension of the newborn. Pharmacoepidemiol Drug Saf. 2009; 18(3):246-52. DOI: 10.1002/pds.1710. View

20.

Pedersen L, Henriksen T, Vestergaard M, Olsen J, Bech B . Selective serotonin reuptake inhibitors in pregnancy and congenital malformations: population based cohort study. BMJ. 2009; 339:b3569. PMC: 2749925. DOI: 10.1136/bmj.b3569. View